Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice - PubMed (original) (raw)
Affiliations
- PMID: 2033514
Comparative Study
Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice
A Giovanni et al. J Pharmacol Exp Ther. 1991 May.
Abstract
In the present study we observed pronounced differences in the capacity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to induce dopaminergic neurotoxicity in several strains of mice. For example, there was no MPTP-induced decrement in neostriatal dopamine content in Ace Swiss-Webster mice and a 92% decrement in Taconic Farms C57 bl mice. Several parameters which could possibly explain this differential sensitivity to MPTP were studied. These include: 1) neostriatal monoamine oxidase-B (MAO-B) activity; 2) the capacity of neostriatal synaptosomes prepared from the mouse strains to accumulate 1-methyl-4-phenylpyridinium (MPP+), the major metabolite of MPTP formed via oxidation by MAO-B; and 3) the neostriatal MPP+ content after MPTP administration to the mice. There were no significant differences in the Km values for MAO-B in the neostriatum among the strains of mice examined. Neostriatal Vmax values for MAO-B differed somewhat among the strains, with a low of 2915 +/- 172 nmol/g of tissue per hr (CD-1 mice from Charles River) and a high of 3884 +/- 203 nmol/g of tissue per hr (C57 bl mice from Taconic Farms). However, Vmax values for MAO-B in the mouse strains did not correlate significantly with the relative sensitivity of the strains to MPTP. There were no significant differences in the capacity of neostriatal synaptosomes prepared from the mouse strains to accumulate MPP+. Studies on the metabolism of MPTP after peripheral administration revealed that there was a significant (P less than .01) positive correlation between the relative sensitivity of the mouse strains to MPTP and their neostriatal MPP+ content after MPTP administration.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK. Giovanni A, et al. J Pharmacol Exp Ther. 1994 Sep;270(3):1000-7. J Pharmacol Exp Ther. 1994. PMID: 7932147 - Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO, Malan SF, Terre'Blanche G, Castagnoli K, Castagnoli N Jr, Bergh JJ, Petzer JP. Ogunrombi MO, et al. Life Sci. 2007 Jul 19;81(6):458-67. doi: 10.1016/j.lfs.2007.06.014. Epub 2007 Jun 28. Life Sci. 2007. PMID: 17655878 - [Experimental model of Parkinson disease: mechanisms and anatomo- pathological characteristics of MPTP neurotoxicity].
Herrero MT, Luquín MR, Obeso JA. Herrero MT, et al. Arch Neurobiol (Madr). 1992 Jul-Aug;55(4):175-82. Arch Neurobiol (Madr). 1992. PMID: 1417423 Review. Spanish.
Cited by
- Strain-specific differences in the expression and activity of Ogg1 in the CNS.
Mosquera DI, Stedeford T, Cardozo-Pelaez F, Sanchez-Ramos J. Mosquera DI, et al. Gene Expr. 2003;11(1):47-53. doi: 10.3727/000000003783992333. Gene Expr. 2003. PMID: 12691525 Free PMC article. - NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S. Wu DC, et al. Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50. doi: 10.1073/pnas.0937239100. Epub 2003 Apr 29. Proc Natl Acad Sci U S A. 2003. PMID: 12721370 Free PMC article. - The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.
Sonsalla PK, Coleman C, Wong LY, Harris SL, Richardson JR, Gadad BS, Li W, German DC. Sonsalla PK, et al. Exp Neurol. 2013 Dec;250:376-83. doi: 10.1016/j.expneurol.2013.10.014. Epub 2013 Oct 30. Exp Neurol. 2013. PMID: 24184050 Free PMC article. - Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration.
Kachroo A, Irizarry MC, Schwarzschild MA. Kachroo A, et al. Exp Neurol. 2010 Jun;223(2):657-61. doi: 10.1016/j.expneurol.2010.02.007. Epub 2010 Feb 24. Exp Neurol. 2010. PMID: 20188092 Free PMC article. - The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.
Sonsalla PK, Wong LY, Winnik B, Buckley B. Sonsalla PK, et al. Exp Neurol. 2010 Feb;221(2):329-34. doi: 10.1016/j.expneurol.2009.11.018. Epub 2009 Dec 4. Exp Neurol. 2010. PMID: 19948168 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous